Saturday 17 October 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024. In the quarter to June 2026, revenue grew 71.2%, EPS fell 32.9%, free cash flow grew 140.5% and total debt rose 187.9%, each against the same quarter a year earlier.

449.74 10.07 −2.19%

Follow MDGL

Alert me

Market cap: $10.6B
P/E: 0.0×
Fwd P/E: −71.3×
Dividend yield: —
F-score: n/a
Altman Z: 10.48
Beneish M: 0.50
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(53.31%)	(49.35%)	(42.49%)	(41.22%)	+8 more TTM periods Free account
ROA Full definition →	(28.77%)	(27.83%)	(25.05%)	(23.74%)
ROIC Full definition →	(787.33%)	(297.52%)	0.00%	0.00%
Return on Tangible Assets Full definition →	(38.86%)	(36.32%)	(30.77%)	(30.17%)
Average Days of Receivables Full definition →	54.67	60.38	51.21	55.83
Free Cash Flow per Share Full definition →	(7.08)	(9.39)	(8.65)	(7.36)
Free Cash Flow Full definition →	(206.28)	(272.61)	(193.99)	(165.54)
Capital Expenditures Full definition →	(8.57)	(4.51)	(4.44)	(4.96)
Other line items
Cash ROIC Full definition →	(12.11%)	(16.02%)	(10.05%)	(7.96%)
Accounts Receivable Turnover Full definition →	9.46	9.10	10.18	10.30
Accounts Payable Turnover Full definition →	3.02	1.53	1.21	0.77
Inventory Turnover Full definition →	1.34	0.94	1.03	0.90
Average Days of Payables Full definition →	115.13	282.77	317.74	466.74
Days of Inventory on Hand Full definition →	331.53	521.21	486.52	719.89
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	38.17%	40.00%	40.54%	40.22%
Selling, General and Administrative Expense of Revenue Full definition →	78.43%	80.75%	84.91%	96.55%
Share Based Compensation of Revenue Full definition →	9.46%	9.82%	10.24%	12.15%
Interest Coverage Full definition →	(10.24)	(11.68)	(13.45)	(17.56)
Operating CF/Net income Full definition →	0.61	0.87	0.66	0.56
Depreciation/Fixed assets Full definition →	0.64	0.83	4.22	1.65
Capex/Depreciation Full definition →	(1.16)	(0.67)	(0.70)	(1.03)
Revenue per Share Full definition →	44.05	39.01	42.72	32.94
Operating CF per Share Full definition →	(6.78)	(9.23)	(8.45)	(7.14)
Capex per Share Full definition →	(0.29)	(0.16)	(0.20)	(0.22)
Capex to Sales Full definition →	0.01	0.00	0.00	0.01

Fold the line items

Columns are period end dates

Stockrow Weekly